How pharma and biotech sponsors approach their outsourcing strategy continues to adapt as the industry responds to the pandemic, inflation, and world events. Outsourcing models, exploring new technologies and needs, as well as CRO and third-party provider relationships are being re-examined with an eye towards efficiency and adaptability. SCOPE’s Mastering an Outsourcing Strategy track will dive into agile outsourcing models, working with technology vendors, and exploring the nuances of outsourcing for decentralized clinical trials. SCOPE’s Relationship and Alliance Management for Clinical Trials track is dedicated to exploring the health of partner relationships, strategies for becoming a partner of choice, and how to overcome challenges in these partnerships.
Solomon Babani , CEO, Crovelis
Jimmy Bechtel, Vice President, Site Engagement, Society for Clinical Research Sites (SCRS)
Rosalie Filling, Vice President, Senior Global Head, R&D Operations, Endo Pharmaceuticals
Scott Sawicki, MA, Senior Director, Strategic Sourcing & Vendor Management, ADC Therapeutics
Wanda Shoer, Head, Strategic Business Operations, Global Development, Johnson & Johnson